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ployed in TGFβ regulation of ANK expression. Phosphate (Pi)
uptake in the presence and absence of an inhibitor of the phos-
phate channels Pit-1 and Pit-2 was evaluated in the context of
TGFb stimulation of ANK expression, as was Pi uptake in the
presence and absence of the alkaline phosphatase inhibitor, lev-
amisole. Finally, inhibition of the L-type calcium channel alpha
1c was studied to determine its role in the regulation of ANK
expression and function in response to TGFβ.
Results: TGFβ produced an increase in ANK expression in all
phases of chondrogenic differentiation but most dramatically at
day 14 (proliferation) and day 32 (mineralizing hypertrophy) of
culture, suggesting a bimodal response to TGFβ during the pro-
liferative and hypertrophic phases of differentiation. To determine
the TGFβ-activated signaling pathway, cells with and without TGFβ
were incubated in the presence of speciﬁc signaling pathway in-
hibitors. The data show that by using the calcium-dependent PKC
inhibitor, Gö6976, there is an inhibition of ANK expression at cell
immaturity (day 4), proliferation (day 14), and mineralizing hyper-
trophy (day 32). To determine if Pi uptake was required for the
enhancement of ANK expression in response to TGFβ, we mea-
sured the effect of Pi uptake on TGFb-stimulated ANK expression
during immaturity (day 4), proliferation (day 14) and hypertrophic
(day 32) phases of differentiation in the ATDC5 cells in the pres-
ence or absence of phosphonoformic acid (PFA), a competitive
inhibitor of the type III Na+/Pi transporter. In the absence of PFA,
ANK expression is increased in response to TGFβ as expected.
However, in the presence of PFA, when Pi is unable to enter
the cells through the Pit-1 transporter, ANK expression is unre-
sponsive to treatment with TGFβ. We also explored the effect
of tissue non-speciﬁc alkaline phosphatase (TNAP) inhibition on
regulating ANK expression in response to TGFβ, particularly at
day 32 when the cells are hypertrophic and normally express high
levels of TNAP. In the presence of levamisole, ANK expression
in response to TGFβ was markedly reduced, as was its ability to
transport inorganic pyrophosphate (PPi) to the extracellular milieu.
These results suggest that Pi availability and uptake by the cells is
necessary for stimulation of ANK expression in response to TGFβ.
Furthermore, the data suggest that the higher the amount of Pi
available for uptake, the greater the stimulation of ANK expres-
sion in response to TGFβ. Since previous studies of endochondral
ossiﬁcation in the growth plate have shown that L-type calcium
channels are essential for chondrogenesis, we investigated the
role of these channels in the TGFβ-stimulated ANK response in
ATDC5 cells. Our results indicated that treatment with nifedipine
to inhibit calcium inﬂux via the L-type channel alpha 1c inhibited
the TGFβ stimulated increase in ANK expression at all phases of
chondrogenesis.
Conclusions: TGFβ stimulation of ANK is dependent upon the
inﬂux of phosphate and calcium into ATDC5 cells at all stages of
differentiation.
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Purpose: Cartilage degradation leading to a loss of joint function
in the arthritides involves proteolytic cleavage of both aggrecan
and collagen. Pro-inﬂammatory cytokines, such as interleukin-1
(IL1) and tumour necrosis factor α (TNFα) induced matrix met-
alloproteinases (MMPs) are considered to play key roles in this
pathologic process. Lithium (LiCl) has been widely used as a drug
for the treatment of manic/depressive (bipolar) and depressive
disorders. Its function is considered to be by inhibition of glycogen
synthase kinase (GSK-3β), a serine/threonine kinase involved in
a multitude of cellular processes. GSK-3β activity is strictly linked
with the NF-κB, MAPK and JNK pathways, which in turn regu-
late IL1 and TNFα-mediated MMP regulation. GSK-3β inhibition
reduces joint inﬂammation and cartilage and bone damage in
murine arthritis model; these events play a key role in the patho-
physiology of arthritis. The aim of this study was to determine
the effects of the lithium (LiCl) on pro-inﬂammatory cytokine IL1,
IL1+oncostatin M (OSM) and TNFα mediated cartilage destruction
and to investigate the mechanisms involved.
Methods: Bovine nasal cartilage explants were stimulated with
cytokines ± LiCl or GSK-3 inhibitors (SB-415286 or TDZD-8) for
14 days. Hydroxyproline release was assayed as a measure of col-
lagen degradation, while collagenolytic activities (active and total)
and gelatinolytic activity in culture supernates were determined
by a bioassay and zymography respectively. Immunoblotting was
used to determine the signalling pathways involved in the action
of LiCl.
Results: LiCl signiﬁcantly decreased cytokine-induced collagen
release from bovine cartilage by the down-regulation of total and
active collagenolytic activities and gelatinolytic activity. The spe-
ciﬁc GSK-3 inhibitor, SB-415286 increased collagen release and
collagenolytic and gelatinolytic activity on cytokine treated bovine
cartilage, while TDZD-8 had no signiﬁcant effect. LiCl decreased
IL1 induced HSP-27 phosphorylation, but had no signiﬁcant effect
on IκB degradation or GSK3β phosphorylation.
Conclusions: This study demonstrates for the ﬁrst time that
lithium, but not speciﬁc GSK-3β inhibitors, can protect cartilage
damage induced by pro-inﬂammatory cytokines via signiﬁcantly
decreasing collagenase and gelatinase activities. These data indi-
cate that lithium mediated cartilage protection may act via inhibition
of an alternative (GSK-independent) signalling pathway and our
data indicates this to be the MAPK pathway p38. This study sug-
gests that lithium, or p38 inhibition, may represent a new therapy
to prevent joint damage.
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Purpose: Joint impact injuries are known to increase the risk
of development of secondary osteoarthritis. Cartilage has poor
regenerative properties therefore treatments are being sought
that can assist in the repair of damaged cartilage within the
joint in an attempt to slow down disease progression. We have
shown previously that mechanical stimulation of human articular
cartilage increases the gene expression of ﬁbroblast growth factor-
18 (FGF18). This novel growth factor is thought to be involved in
chondrocyte proliferation and cartilage matrix repair. This study
aimed to ﬁnd out whether FGF18 has a reparative effect on
cartilage that has been damaged by a traumatic impact load,
and to compare the effects of this growth factor with the more
extensively studied FGF2.
Methods: Full-depth circular explants (5 mm in diameter) of ar-
ticular cartilage were removed from the underlying subchondral
bone of bovine carpometacarpal joints (n=3) and cultured for 48
h. The explants were then subjected to a single impact load using
a 500 g mass dropped from a height of 25 mm in a drop tower.
The duration of each impact was approximately 3 ms with an im-
pact energy of 0.13 J. Following impact, the loaded explants were
cultured, along with unloaded controls, for 15 days in the pres-
ence of FGF2 or FGF18 (0, 10, 30 and 100 ng/ml). The medium
